Xuening Yang - Guangdong Provincial People's Hospital

基本信息

Career Trajectory

Bio

主要研究方向肺结节、早期肺癌的诊疗策略，肺癌的微创外科治疗，以外科为主的肺癌多学科综合治疗。

从事肺癌临床及教学工作二十余年。担任中国抗癌协会肺癌专业委员会副主任委员。

获得国家科学技术进步奖二等奖，广东省科技进步奖一等奖。

Research Interests

Papers共 27 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

729Tip A Real-World Study to Explore Therapeutic Changing Mode of Locally Therapy During 1L Lorlatinib Treatment in Unresectable ALK+ NSCLC Patients

J. Zhao,X. Yang,X. Zhai

Annals of Oncology (2024): S1676

Cited0Views0Bibtex

A Real-World Study to Explore Therapeutic Changing Mode of Locally Therapy During 1L Lorlatinib Treatment in Unresectable ALK Plus NSCLC Patients

J. Zhao,X. Yang,X. Zhai

ANNALS OF ONCOLOGY (2024)

Cited0Views0Bibtex

High Dose Hyperfractionated Thoracic Radiotherapy Vs. Standard Dose for Limited Stage Small-Cell Lung Cancer: A Multicenter, Open-Label Randomized, Phase 3 Trial

J. Yu, L. Jiang, L. Zhao, X. Wang,X. Yang, D. Yang,M. Zhuo,H. Chen,Y. D. Zhao, F. Zhou, Q. Li,Z. Zhu,L. Chu,Z. Ma, Q. Wang,Y. Qu,W. Huang,M. Zhang, T. Gu, S. Liu, Y. Yang, J. Yang, H. Yu, R. Yu,J. Zhao,A. Shi

International Journal of Radiation OncologyBiologyPhysicsno. 2 (2023): S1-S1

Cited0Views0WOSBibtex

36P Prevalence, Clinical Characteristics, and Treatment Outcomes of Patients with BRAF-mutated Advanced NSCLC in China: A Real-World Multi-Center Study

B. Jia,J. Zhao,B. Jin,F. Zhang,S. Wang, L. Zhang,Z. Wang,T. An, Y. Wang,M. Zhuo, J. Li,X. Yang,S. Li,H. Chen,Y. Chi, J. Wang,X. Zhai,Y. Tai, Y. Liu, G. Guan

Journal of Thoracic Oncologyno. 4 (2023): S61-S61

Cited0Views0Bibtex

P84.15 Alectinib in Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer As First-Line or Sequential Treatment in China

X. Yang,X. Dong, Y. Liu,B. Jin,J. Wang, Y. Wang, Y. Zhang,M. Zhuo,J. Zhao

Journal of Thoracic Oncology（2021）

Cited2Views0Bibtex

1961P the Landscape of PTPRT Mutations and Correlation with TMB in Chinese Solid Tumour Patients

Z. Zhang,X. Zhou,P. Liu,X. Yang, H. Chen, X. Zhao,Q. Hu,H. Sun,A. Yang,Y. Bai

Annals of Oncology（2020）

Cited0Views0Bibtex

Lenvatinib Plus PD-1 Blockade in Advanced Bile Tract Carcinoma

J. Lin,X. Yang,S. Zhao,J. Long,J. Pan,K. Hu,L. Zhao,L. Huo,X. Sang,K. Wang, H. Zhao

Annals of Oncology（2019）

Cited11Views0Bibtex

CTONG 1103: Erlotinib Versus Gemcitabine Plus Cisplatin As Neo-Adjuvant Treatment for Stage IIIA-N2 EGFR-mutation Non-Small Cell Lung Cancer (EMERGING): A Randomised Study

W-Z. Zhong,Y-L. Wu,K-N. Chen,C. Chen,C-D. Gu,Q. Wang,J. Wang,W. Mao,G-B. Qiao,Y. Cheng,L. Xu,C-L. Wang, M-W. Chen,X-N. Yang, H-J. Chen,H-H. Yang,J-J. Yang,Q. Zhou

Annals of Oncology（2018）

Cited15Views0WOSBibtex

P2.01-01 the Impact of Anlotinib on Brain Metastases of NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)

W. Liang,Y. Zhao,Y. Zhang, X. Han,X. Yang,J. He,K. Li,B. Han

JOURNAL OF THORACIC ONCOLOGY（2018）

Cited3Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Xuening Yang(杨学宁)

主任医师

Papers共 27 篇Author StatisticsCo-AuthorSimilar Experts